These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6389352)

  • 1. Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin.
    Ferrante A; Rowan-Kelly B; Paton JC
    Infect Immun; 1984 Nov; 46(2):585-9. PubMed ID: 6389352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivities of human monocytes and epithelial cells to pneumolysin are different.
    Hirst RA; Yesilkaya H; Clitheroe E; Rutman A; Dufty N; Mitchell TJ; O'Callaghan C; Andrew PW
    Infect Immun; 2002 Feb; 70(2):1017-22. PubMed ID: 11796644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis.
    Ng EW; Samiy N; Rubins JB; Cousins FV; Ruoff KL; Baker AS; D'Amico DJ
    Retina; 1997; 17(6):521-9. PubMed ID: 9428015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin.
    Nandoskar M; Ferrante A; Bates EJ; Hurst N; Paton JC
    Immunology; 1986 Dec; 59(4):515-20. PubMed ID: 3804376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae.
    Paton JC; Lock RA; Hansman DJ
    Infect Immun; 1983 May; 40(2):548-52. PubMed ID: 6840851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity.
    Saunders FK; Mitchell TJ; Walker JA; Andrew PW; Boulnois GJ
    Infect Immun; 1989 Aug; 57(8):2547-52. PubMed ID: 2744861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human complement by the pneumococcal toxin pneumolysin.
    Paton JC; Rowan-Kelly B; Ferrante A
    Infect Immun; 1984 Mar; 43(3):1085-7. PubMed ID: 6698602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.
    Virolainen A; Jero J; Käyhty H; Karma P; Eskola J; Leinonen M
    Clin Diagn Lab Immunol; 1995 Nov; 2(6):704-7. PubMed ID: 8574834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
    Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumolysin activates phospholipase A in pulmonary artery endothelial cells.
    Rubins JB; Mitchell TJ; Andrew PW; Niewoehner DE
    Infect Immun; 1994 Sep; 62(9):3829-36. PubMed ID: 8063399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae.
    Berry AM; Alexander JE; Mitchell TJ; Andrew PW; Hansman D; Paton JC
    Infect Immun; 1995 May; 63(5):1969-74. PubMed ID: 7729909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin.
    Cruse G; Fernandes VE; de Salort J; Pankhania D; Marinas MS; Brewin H; Andrew PW; Bradding P; Kadioglu A
    J Immunol; 2010 Jun; 184(12):7108-15. PubMed ID: 20483738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of pneumolysin to pulmonary endothelial cells in vitro.
    Rubins JB; Duane PG; Charboneau D; Janoff EN
    Infect Immun; 1992 May; 60(5):1740-6. PubMed ID: 1563759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
    Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
    J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae.
    Rossjohn J; Gilbert RJ; Crane D; Morgan PJ; Mitchell TJ; Rowe AJ; Andrew PW; Paton JC; Tweten RK; Parker MW
    J Mol Biol; 1998 Nov; 284(2):449-61. PubMed ID: 9813129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae.
    Lock RA; Paton JC; Hansman D
    Microb Pathog; 1988 Dec; 5(6):461-7. PubMed ID: 3149709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.
    Paton JC; Ferrante A
    Infect Immun; 1983 Sep; 41(3):1212-6. PubMed ID: 6885160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumolysin released during Streptococcus pneumoniae autolysis is a potent activator of intracellular oxygen radical production in neutrophils.
    Martner A; Dahlgren C; Paton JC; Wold AE
    Infect Immun; 2008 Sep; 76(9):4079-87. PubMed ID: 18559434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection.
    Cockeran R; Anderson R; Feldman C
    Curr Opin Infect Dis; 2002 Jun; 15(3):235-9. PubMed ID: 12015456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of pneumolysin to pulmonary alveolar epithelial cells.
    Rubins JB; Duane PG; Clawson D; Charboneau D; Young J; Niewoehner DE
    Infect Immun; 1993 Apr; 61(4):1352-8. PubMed ID: 8454338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.